117 related articles for article (PubMed ID: 8134127)
41. Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family.
Lomax ME; Barnes DM; Gilchrist R; Picksley SM; Varley JM; Camplejohn RS
Oncogene; 1997 Apr; 14(15):1869-74. PubMed ID: 9150393
[TBL] [Abstract][Full Text] [Related]
42. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
43. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
44. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
[TBL] [Abstract][Full Text] [Related]
45. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
46. p53 gene mutation spectrum in human unknown primary tumors.
Bar-Eli M; Abbruzzese JL; Lee-Jackson D; Frost P
Anticancer Res; 1993; 13(5A):1619-23. PubMed ID: 8239543
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR
Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522
[TBL] [Abstract][Full Text] [Related]
48. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
[TBL] [Abstract][Full Text] [Related]
49. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review.
Soussi T; Leblanc T; Baruchel A; Schaison G
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):33-6. PubMed ID: 8511038
[TBL] [Abstract][Full Text] [Related]
50. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
[TBL] [Abstract][Full Text] [Related]
51. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
52. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma.
Bot FJ; Sleddens HF; Dinjens WN
Diagn Mol Pathol; 1998 Dec; 7(6):295-301. PubMed ID: 10207667
[TBL] [Abstract][Full Text] [Related]
53. Polymorphism at codon 213 within the p53 gene.
Carbone D; Chiba I; Mitsudomi T
Oncogene; 1991 Sep; 6(9):1691-2. PubMed ID: 1923533
[TBL] [Abstract][Full Text] [Related]
54. Synchronous male breast carcinoma and soft tissue sarcoma occurring within a cancer family.
Reinbach D; McGregor JR; O'Dwyer PJ; George WD
Eur J Surg Oncol; 1992 Dec; 18(6):624-6. PubMed ID: 1335887
[TBL] [Abstract][Full Text] [Related]
55. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
Malkin D; Li FP; Strong LC; Fraumeni JF; Nelson CE; Kim DH; Kassel J; Gryka MA; Bischoff FZ; Tainsky MA
Science; 1990 Nov; 250(4985):1233-8. PubMed ID: 1978757
[TBL] [Abstract][Full Text] [Related]
56. Germline p53 mutation in a patient with multiple primary cancers.
Kimura K; Shinmura K; Hasegawa T; Beppu Y; Yokoyama R; Yokota J
Jpn J Clin Oncol; 2001 Jul; 31(7):349-51. PubMed ID: 11518751
[TBL] [Abstract][Full Text] [Related]
57. A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
Speiser P; Gharehbaghi-Schnell E; Eder S; Haid A; KovarÃk J; Nenutil R; Sauter G; Schneeberger CH; Vojtesek B; Wiltschke CH; Zeillinger R
Br J Cancer; 1996 Jul; 74(2):269-73. PubMed ID: 8688334
[TBL] [Abstract][Full Text] [Related]
58. Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene.
Kikuchi T; Rempel SA; Rutz HP; de Tribolet N; Mulligan L; Cavenee WK; Jothy S; Leduy L; Van Meir EG
Cancer Res; 1993 Mar; 53(5):957-61. PubMed ID: 8439970
[TBL] [Abstract][Full Text] [Related]
59. p53: functions, mutations and sarcomas.
Hung J; Anderson R
Acta Orthop Scand Suppl; 1997 Feb; 273():68-73. PubMed ID: 9057590
[TBL] [Abstract][Full Text] [Related]
60. Single base pair germ-line deletion in the p53 gene in a cancer predisposed family.
Hamelin R; Barichard F; Henry I; Junien C; Thomas G
Hum Genet; 1994 Jul; 94(1):88-90. PubMed ID: 8034301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
